Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy

The frequency, manifestations, and duration of prolonged cytopenias after first-line fludarabine combination chemotherapy

(2009) S. Gill et al.   ANNALS OF ONCOLOGY

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

(2009) Pierre Fenaux et al.   LANCET ONCOLOGY

Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia

(2008) C. S. Tam et al.   BLOOD

High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone in previously untreated patients with advanced stage follicular lymphoma

(2008) S. Montoto et al.   HAEMATOLOGICA

Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study

(2008) S. Sacchi et al.   HAEMATOLOGICA

Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparator

(2008) K E Herbert et al.   LEUKEMIA